Prevalence and determinants of peripheral neuropathy among diabetics in a rural cum costal area of Villupuram district, Tamil Nadu

Sankari Mansa Devi H, Vishnu Prasad R, Joy Bazroy, Zile Singh


Background: Diabetes mellitus is characterised by persistent hyperglycaemia that may be due to absolute or relative insulin deficiency. It was estimated that there would be 285 million diabetics by 2010 in the world. This estimate is projected to increase by 65% to become 438 million in the year 2030. Similarly in India it is estimated to increase by 58% from 51 million people in the year 2010 to 87 million people by the year 2030.  

Methods: The study was carried out as cross sectional study among 235 diabetic OPD attendants of rural health centre aged 30 years and above. TCSS was used for diagnosis diabetic peripheral neuropathy. Data was entered in MS excel 2007 and analysis was done using SPSS version 17.0. Chi square test was applied to find statistical difference in proportions and a p value of <0.05 was considered statistically significant.  

Results: The overall prevalence of peripheral neuropathy among the study participants was observed to be 13.2%, while none of the study subjects presented with severe form of the disease. Nearly half of the patient who participated in the study also had co existing systemic hypertension. Also 12.3% of the study subjects had a positive history of foot ulcers.

Conclusions: The prevalence of DPN increased with increasing age and it is observed to be associated with duration of diabetes, physical activity, smoking habit and systemic hypertension.



Diabetes mellitus, Peripheral neuropathy, Risk factors, Prevalence

Full Text:



Gupta V. Type 2 diabetes mellitus in India. Report submitted to South Asia Network for Chronic Disease, 2012. Available at:

Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation Community. Diabetes Care. 2008;31:1837-41.

Emanuele NV, Swade TF, Emanuele MA. Consequences of alcohol use in diabetics. Alcohol Health Res World. 1998;22:211-9.

Tesfaye S. Epidemiology and etiology of diabetic peripheral neuropathies. Adv Stud Med. 2004;4:S1014-21.

Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518-22.

Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28:8-14.

Tesfaye S, Stevens L, Stephenson J, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377-84.

Young M, Boulton A, MacLeod A, Williams D, Sonksen P. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150-4.

Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. JAPI. 2002;50:546-50.

Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES‐55). Diabet Med. 2008;25:407-12.

Mørkrid K, Ali L, Hussain A. Risk factors and prevalence of diabetic peripheral neuropathy: a study of type 2 diabetic outpatients in Bangladesh. Int J Diab Dev Countries. 2010;30:11.

Dutta A, Naorem S, Singh TP, Wangjam K. Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics. Int J Diab Dev Countries. 2005;25:30-3.

Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, et al. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Acta Neurol Scand. 2006;114:384-91.

Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff M, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr. 2012;4:21.